The first choice of pharmacological treatment for MDD and most anxiety disorders are selective serotonin reuptake inhibitors (SSRIs) [5, 6], blocking the 5-HT transporter (5-HTT) [7]. The gene discussed is SLC6A4; the disease is major depressive disorder.